2007 Annual Meeting | Therapy of Pediatric Genetic Neurological Disorders

�鶹��ýӳ��

2007 Annual Meeting | Therapy of Pediatric Genetic Neurological Disorders

Date Sunday 04/29/07

Time 06:00 PM - 09:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Dinner Seminar

Director(s) E. S. Roach, MD, F�鶹��ýӳ��

Topic(s) Child Neurology and Developmental Neurology

Learning Objectives Participants should know some general approaches to the treatment of genetic neurological disorders; recognize the clinical features of selected genetic disorders for which therapy is available; and know the available treatments for selected genetic neurological conditions.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
05:45 PM - 09:00 PM		Dinner
06:15 PM - 07:00 PM		CSF Neurotransmitter Analysis to Identify Treatable Genetic Neurological Conditions Keith Hyland, PhD
07:00 PM - 07:45 PM		Dietary and Nutritional Therapy of Genetic Neurological Disorders E. S. Roach, MD, F�鶹��ýӳ��
07:50 PM - 08:00 PM		Break
08:00 PM - 08:45 PM		Gene and Gene Product Replacement Michael M. Dowling, MD, PhD, F�鶹��ýӳ��
08:45 PM - 09:00 PM		Questions and Answers

Faculty Disclosures
E. S. Roach, MD, F�鶹��ýӳ��	No disclosure on file
Keith Hyland, PhD	No disclosure on file
Michael M. Dowling, MD, PhD, F�鶹��ýӳ��	Dr. Dowling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Dowling has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NHLBI. The institution of Dr. Dowling has received research support from NIH.